Your browser doesn't support javascript.
loading
Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma.
Hirayama, Alexandre V; Kimble, Erik L; Wright, Jocelyn H; Fiorenza, Salvatore; Gauthier, Jordan; Voutsinas, Jenna M; Wu, Qian; Yeung, Cecilia C S; Gazeau, Nicolas; Pender, Barbara S; Kirchmeier, Delaney R; Torkelson, Aiko; Chutnik, Abigail N; Cassaday, Ryan D; Chapuis, Aude G; Green, Damian J; Kiem, Hans-Peter; Milano, Filippo; Shadman, Mazyar; Till, Brian G; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J.
Afiliação
  • Hirayama AV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Kimble EL; Department of Medicine, University of Washington, Seattle, WA.
  • Wright JH; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Fiorenza S; Department of Medicine, University of Washington, Seattle, WA.
  • Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Voutsinas JM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Wu Q; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Yeung CCS; Department of Medicine, University of Washington, Seattle, WA.
  • Gazeau N; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.
  • Pender BS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Kirchmeier DR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Torkelson A; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.
  • Chutnik AN; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.
  • Cassaday RD; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Chapuis AG; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
  • Green DJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Kiem HP; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Milano F; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Till BG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Maloney DG; Department of Medicine, University of Washington, Seattle, WA.
  • Turtle CJ; Department of Medicine, University of Washington, Seattle, WA.
Blood Adv ; 8(2): 453-467, 2024 01 23.
Article em En | MEDLINE | ID: mdl-37903325
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma Difuso de Grandes Células B Limite: Adult / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma Difuso de Grandes Células B Limite: Adult / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article